New Insights in Occult Psoriatic Arthritis

被引:5
|
作者
Palazzi, Carlo [1 ,2 ]
D'Angelo, Salvatore [1 ,2 ]
Lubrano, Ennio [3 ]
Olivieri, Ignazio [1 ,2 ]
机构
[1] San Carlo Hosp, Rheumatol Dept Lucania, Potenza, Italy
[2] Madonna delle Grazie Hosp, Matera, Italy
[3] Univ Molise, Dept Hlth Sci, Acad Rheumatol Unit, Campobasso, Italy
关键词
ANKYLOSING SPONDYLITIS; ASYMPTOMATIC; OCCULT PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHIES; INFLAMMATORY-BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; PREVALENCE; SPONDYLOARTHROPATHY; ALPHA;
D O I
10.3899/jrheum.120236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the 1970s, asymptomatic involvement of several musculoskeletal structures was described in patients with psoriatic arthritis (PsA). We recently designated this clinical condition as occult PsA. This concept addresses an "underground" inflammatory process that can eventually cause structural damage. The percentage of PsA cases occurring in an occult manner remains to be determined but it does not seem small. From a teaching perspective, we suggest differentiating occult PsA into 3 subsets: real occult PsA, characterized by a continuous asymptomatic course; temporary occult PsA, in which the clinical course remains asymptomatic for a period; and limited occult PsA, which occurs asymptomatically in some areas of the body but is clinically evident in others. Some serum biomarkers could identify patients to be studied with imaging techniques to discover real occult PsA. Since an asymptomatic course was also reported for other spondyloarthropathies, the concept of occult arthritis could be expanded to the whole field of such conditions. (J Rheumatol Suppl. 2012 Jun;89:22-23; doi:10.3899/jrheum.120236)
引用
收藏
页码:22 / 23
页数:2
相关论文
共 50 条
  • [31] New classification criteria in psoriatic arthritis
    Fernandez Sueiro, Jose Luis
    Pertega Diaz, Sonia
    REUMATOLOGIA CLINICA, 2007, 3 : 10 - 14
  • [32] New approved drugs for psoriatic arthritis
    Perrotta, F. M.
    Lubrano, E.
    REUMATISMO, 2016, 68 (02) : 57 - 64
  • [33] New therapies for psoriasis and psoriatic arthritis
    Ritchlin, Christopher T.
    Krueger, James G.
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (03) : 204 - 210
  • [34] New pathways of treatment for psoriatic arthritis
    Mease, Philip
    LANCET, 2017, 389 (10086): : 2268 - 2270
  • [35] WHAT IS NEW (WIN) IN PSORIATIC ARTHRITIS
    Lories, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 3 - 3
  • [36] New therapeutic targets in psoriatic arthritis
    Montilla Morales, Carlos
    Gomez-Castro, Susana
    Sanchez, Mariola
    Lopez, Ruth
    Hidalgo, Cristina
    Del Pino-Montes, Javier
    REUMATOLOGIA CLINICA, 2012, 8 : S15 - S19
  • [37] New Biological Treatments for Psoriatic Arthritis
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (10): : 643 - 645
  • [38] A new instrument for the screening of psoriatic arthritis among psoriatic patients
    De Marco, G.
    Marchesoni, A.
    Manara, M.
    Gisondi, P.
    Idolazzi, L.
    Ramonda, R.
    Piaserico, S.
    Cauli, A.
    Cimmino, M. A.
    Tomatis, V.
    Salvarani, C.
    Scrivo, R.
    Zanetti, A.
    Carrara, G.
    Scire, C. A.
    Cattaneo, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2025, 43 (01) : 28 - 33
  • [39] A new enthesitis index for psoriatic arthritis
    Healy, Paul
    Helliwell, Philip
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1815 - 1815
  • [40] NEW TYPE OF DRUG FOR PSORIATIC ARTHRITIS
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2014, 114 (07) : 23 - 23